OtherClosing soon
6550--FY27 Qiagen Reagents and Controls
VETERANS AFFAIRS, DEPARTMENT OF › 248-NETWORK CONTRACT OFFICE 8 (36C248)
Response deadlineAug 28, 2026 10:00 AM EDT
View official notice on SAM.gov ↗ (opens in a new tab)
Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice.
Read the Data Disclaimer.
Key decision factors
- Response deadline
- Aug 28, 2026 10:00 AM EDT
- Posted
- Aug 24, 2026 12:00 AM EDT
- Notice type
- Special Notice
- Set-aside
- Not provided or not applicable
- NAICS
- 334516
- PSC
- 6550
- Place of performance
- Not specified
- Current status
- Closing soon
Notice details
- Official status
- Closing soon
- Normalized group
- Other
- Notice ID
- 3e2856bf56f94186a78754008931dd22
- Solicitation number
- 36C24826Q1168
Description
Displayed as sanitized plain text from SAM.gov. Retrieved Aug 25, 2026 5:16 PM EDT.
The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II reagents and controls used for Interferon Gamma Release Assay (IGRA) testing at the James A. Haley Veterans Hospital (JAHVH). The contract will be established as a five year BPA (Base Year + 4 Option Years). The applicable NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), PSC 6640. This notice is not a solicitation. No solicitation will be issued. The Government intends to solicit and negotiate with only one source, as the required QuantiFERON TB Gold Plus II reagents are exclusively manufactured by QIAGEN and are uniquely compatible with the DiaSorin LIAISON XL analyzer currently in use at JAHVH. Interested parties may submit capability statements demonstrating the ability to provide fully compatible supplies no later than 10:00 AM ET, August 28, 2026, to Quentin.Ford@va.gov. Proprietary information must be clearly marked. The Government will evaluate responses solely to determine whether competition is viable; however, a decision not to compete remains at the Government s discretion. Point of Contact: Quentin Ford, Contracting Officer, NCO 8 Statement of Need QIAGEN QuantiFERON TB Gold Plus II Reagents and Controls Overview: The Pathology and Laboratory Medicine Service at JAHVH requires FDA approved, DiaSorin compatible reagents and controls for QuantiFERON TB Gold Plus II testing to support in house IGRA testing for Veterans and employee TB screening. Requirement Summary: Provide QIAGEN QuantiFERON TB Gold Plus II reagents and controls fully compatible with the DiaSorin LIAISON XL analyzer. Support continuous IGRA testing for clinical and occupational health needs. Furnish monthly deliveries of required reagents; shipping included. Supply products meeting CAP, JCAHO, and VA laboratory standards. No site preparation required equipment already installed. Routine daily maintenance and QC performed by VA staff. Equipment maintenance is covered under a separate DiaSorin service contract.
Personalized relevance
Would this fit your company?
Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.
Create Free Account
Pursuit risk (separate from your match score)
Strong pursuit warning
This notice contains language indicating a sole-source or otherwise restricted procurement. Review the cited evidence before investing time in a response.
Detected in
- Description“The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II re”
Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.